Css LLC Atea Pharmaceuticals, Inc. Transaction History

Css LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$2.8 - $3.35 $33,600 - $40,200	12,000 Added 108.93%	23,016 $70,000
Q3 2023 Nov 14, 2023	SELL	$3.0 - $3.79 $7,800 - $9,854	-2,600 Reduced 19.1%	11,016 $33,000
Q2 2023 Aug 14, 2023	BUY	$3.21 - $5.06 $43,707 - $68,896	13,616 New	13,616 $50,000
Q3 2021 Nov 15, 2021	BUY	$21.33 - $35.06 $116,867 - $192,093	5,479 New	5,479 $192,000

112

52.4M

900

126K

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $270M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.